Skip to main content
HLB INC. logo

HLB INC. — Investor Relations & Filings

Ticker · 028300 ISIN · KR7028300002 KO Manufacturing
Filings indexed 553 across all filing types
Latest filing 2022-01-11 Regulatory Filings
Country KR South Korea
Listing KO 028300

About HLB INC.

https://www.hlb.global/

HLB INC. is a biopharmaceutical company focused on developing new global anti-cancer drugs. The company's core activities center on advancing a pipeline of novel therapeutics through its worldwide network, which includes subsidiaries like Elevar Therapeutics and Immunomic Therapeutics. In addition to its primary focus on oncology, HLB's affiliated companies are involved in other life science areas, such as developing and manufacturing in vitro diagnostic medical devices, peptide-based biomaterials, and quasi-drugs. The group also has operations in composite materials and shipbuilding, reflecting its diversified origins.

Recent filings

Filing Released Lang Actions
기타시장안내(약명및영문명)
Regulatory Filings Classification · 1% confidence The document is a short notice regarding a change in the company's stock name (from '에이치엘비' to 'HLB'). It does not contain financial statements, management discussions, or proxy materials. As it is a miscellaneous regulatory announcement regarding corporate identity/listing details that does not fit into specific categories like share issuance or delisting, it falls under the general regulatory filing category.
2022-01-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure by company insiders (directors/executives) regarding their shareholdings and changes therein. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers insider trades and ownership reports by company directors and executives.
2022-01-07 Korean
합병등종료보고서(합병)
M&A Activity Classification · 1% confidence The document is titled '합병등종료보고서' (Report on Completion of Merger, etc.) and is filed with the Financial Supervisory Service (FSS) in South Korea. It details the finalization of a merger between HLB Co., Ltd. and FA Co., Ltd., including the timeline, financial impact, and legal status of the merger. This falls under M&A activity documentation.
2022-01-04 Korean
[첨부추가]타법인주식및출자증권취득결정
M&A Activity Classification · 1% confidence The document is a formal regulatory filing from HLB (에이치엘비) regarding the acquisition of shares in another company (주식회사 노터스). It details the acquisition price, number of shares, purpose of acquisition, and financial status of the target company. This type of disclosure is a standard corporate announcement regarding M&A activity or strategic investment, which falls under the 'M&A Activity' category.
2021-12-27 Korean
불성실공시법인지정예고
Regulatory Filings Classification · 1% confidence The document is a formal notice from a regulatory body (KOSDAQ) regarding the 'pre-designation of an unfaithful disclosure corporation' (불성실공시법인지정예고). It details the type of disclosure failure, the specific regulatory articles involved, and the potential consequences (trading suspension or eligibility review). This fits the definition of a regulatory announcement regarding compliance and legal/regulatory status, which falls under the RNS category.
2021-12-22 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement regarding the setting of a record date for a shareholder meeting (Annual General Meeting). It is not the meeting materials themselves, but a formal notice of the record date for shareholder rights. Given the nature of the filing as a regulatory notification regarding corporate actions, it fits best under the RNS category as a general regulatory announcement.
2021-12-16 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.